Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Silo Pharma, Inc. shows stable business momentum based on AlphaOS pipeline evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 22d ago
SILO's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on SILO.
Free accounts see more of this; Premium sees all of it.
Reported figures for Silo Pharma, Inc. — research only, not investment advice.
Updated
What happened recently for Silo Pharma, Inc. (SILO) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
SILO's AI investment thesis
Upgrade to Premium for SILO's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$1.75
Market cap
$2.78M
Profitable
No
Revenue $18,030.00
Net income
$-1.65M
FY Sep 7, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Silo Pharma, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Silo Pharma, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.